Legal Newsline

Friday, February 28, 2020

N.J. AG announces agreement with pharmacy

By Bryan Cohen | Mar 19, 2013


NEWARK, N.J. (Legal Newsline) - New Jersey Attorney General Jeffrey Chiesa says a Tinton Falls-based pharmacy agreed to temporarily stop all pharmacy operations after the pharmacy voluntarily recalled bags of intravenous magnesium sulfate solution.

Under the terms of an interim voluntary consent order between the State Board of Pharmacy and Med Prep Consulting Inc., the pharmacy temporarily halted all pharmacy operations through at least March 22, including the shipping and production of medications. The consent order, which does not represent an admission of wrongdoing or a disciplinary action, follows the pharmacy's voluntary recall of magnesium sulfate.

The pharmacy recalled bags of the intravenous solution that were delivered to a hospital in Connecticut and appeared to be contaminated with visible floating particles. The recall includes magnesium sulfate products dispensed to additional facilities in Pennsylvania and New Jersey.

"The State Board of Pharmacy and Med Prep have agreed that the pharmacy will stop producing and shipping medications until additional information about the potentially contaminated products can be gathered and analyzed," Chiesa said. "Our Enforcement Bureau investigators are working closely with the State Board of Pharmacy, State Department of Health and the U.S. Food and Drug Administration to fully investigate the circumstances surrounding this incident."

Health Commissioner Mary O'Dowd said that magnesium sulfate is administered intravenously for various conditions and the Department of Health is exercising caution with the potentially contaminated solution by removing the product from use.

The Health Department is sending voluntary recall notices to hospitals around New Jersey. Chiesa's office encouraged health professionals to visibly check any Med Prep or other products prior to using them.

Want to get notified whenever we write about ?

Sign-up Next time we write about , we'll email you a link to the story. You may edit your settings or unsubscribe at any time.